United States securities and exchange commission logo





                          February 20, 2024

       David Lennon
       Chief Executive Officer
       Aadi Bioscience, Inc.
       17383 Sunset Boulevard Suite A250
       Pacific Palisades, CA 90272

                                                        Re: Aadi Bioscience,
Inc.
                                                            Registration
Statement on Form S-3
                                                            Filed February 12,
2024
                                                            File No. 333-277018

       Dear David Lennon:

              This is to advise you that we have not reviewed and will not
review your registration
       statement.

               Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you
       that the company and its management are responsible for the accuracy and
adequacy of their
       disclosures, notwithstanding any review, comments, action or absence of
action by the staff.

                                                        Please contact Cindy
Polynice at 202-551-8707 with any questions.




                          Sincerely,


                          Division of Corporation Finance

                          Office of Life Sciences
       cc:                                              Robert Wernli, Esq.